Widely used:Recently Viewed
Clear All
$84.20
$-0.68
(-0.80%)
As on 18-Mar-2025 14:42EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$4,146 Mln
P/E Ratio
19.65
P/B Ratio
2.32
Industry P/E
41.5
Debt to Equity
0.69
ROE
0.13 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
4.27
CFO
$1,931.72 Mln
EBITDA
$2,958.86 Mln
Net Profit
$1,053.99 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Prestige Consumer Healthcare (PBH)
| 7.82 | -2.09 | 4.74 | 12.76 | 14.62 | 23.32 | 7.57 |
|
BSE Sensex
| -3.77 | -0.92 | -6.67 | 3.66 | 9.18 | 19.75 | 10.11 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Prestige Consumer Healthcare (PBH)
| 27.30 | -2.20 | 3.22 | 73.93 | -13.90 | 31.15 | -29.45 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 124.71 | 5,944.99 | -- | -231.63 | |
| 32.21 | 6,270.53 | -- | 38.11 | |
| 57.11 | 5,909.22 | 45.54 | 23.56 | |
| 9.54 | 10,862.58 | -- | -3.24 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates... in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Address: 660 White Plains Road, Tarrytown, NY, United States, 10591 Read more
Chairman, President & CEO
Mr. Ronald M. Lombardi
Senior Vice President of Operations
Mr. Jeffrey Zerillo
Headquarters
Tarrytown, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Prestige Consumer Healthcare Inc (PBH) stood at $ 3,432 Mln as on 31-Dec-24
The share price of Prestige Consumer Healthcare Inc (PBH) is $84.20 (NYSE) as of 18-Mar-2025 14:42 EDT. Prestige Consumer Healthcare Inc (PBH) has given a return of 14.62% in the last 3 years.
Prestige Consumer Healthcare Inc (PBH) has a market capitalisation of $ 4,146 Mln as on 17-Mar-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Prestige Consumer Healthcare Inc (PBH) is 2.32 times as on 17-Mar-2025, a 56% discount to its peers’ median range of 5.23 times.
The P/E ratio of Prestige Consumer Healthcare Inc (PBH) is 19.65 times as on 17-Mar-2025, a 53% discount to its peers’ median range of 41.50 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Prestige Consumer Healthcare Inc (PBH) and enter the required number of quantities and click on buy to purchase the shares of Prestige Consumer Healthcare Inc (PBH).
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Address: 660 White Plains Road, Tarrytown, NY, United States, 10591
The CEO & director of Mr. Ronald M. Lombardi. is Prestige Consumer Healthcare Inc (PBH), and CFO & Sr. VP is Mr. Jeffrey Zerillo.
There is no promoter pledging in Prestige Consumer Healthcare Inc (PBH).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,132
|
|
|
665
|
|
|
610
|
|
|
591
|
| Prestige Consumer Healthcare Inc. (PBH) | Ratios |
|---|---|
|
Return on equity(%)
|
12.33
|
|
Operating margin(%)
|
29.49
|
|
Net Margin(%)
|
19.14
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Prestige Consumer Healthcare Inc (PBH) was $0 Mln.
